MGI Tech
Oxford Nanopore Technologies Sues BGI, Affiliates for Sequencing Technology Contract Breach
Among other demands, Oxford Nanopore asked the UK court to grant an injunction to prevent the sale and licensing of BGI's nanopore sequencing products.
Emirati Genome Program Yields New Public Health Initiatives, Including Premarital Carrier Screening
Premium
The United Arab Emirates is employing three short- and long-read sequencing platforms to enable these initiatives, which also include PGx testing and HLA typing.
At the American Society of Human Genetics annual meeting last week, the company highlighted new spatial transcriptomics and proteomics analysis workflows.
Oxford Nanopore Withdraws Application to Serve BGI Affiliates Subpoenas for Intended Lawsuit
ONT filed the application in September, weeks after it said it planned to sue BGI and its affiliates in England and Wales after BGI unveiled its first nanopore sequencer.
MGI Tech, OncoDNA Ink Comarketing Deal for NGS-Based Cancer Panel
Under the partnership, the companies have made OncoDNA's OncoDeep cancer sequencing kit compatible with MGI's DNBSeq sequencing platforms.